Sign In
Buy INT
$24.26
+0 (+0%)
At Close: Sep 14, 2023
Late-stage clinical studies advancing in soft tissue sarcoma and presurgical triple-negative breast cancer Over 200 patients enrolled in completed INT230-6 studies with a peer-reviewed paper published
Intensity Therapeutics, Inc. to Present Two Posters at the 2025 San Antonio Breast Cancer Symposium
07:47am, Thursday, 11'th Dec 2025
Poster PS5-08-16 Reports Early Observations from the INVINCIBLE-4 Study, an Ongoing Randomized, Presurgical Phase 2 Clinical Trial for Triple Negative Breast Cancer continue to show favorable safety 5
The paper features a comprehensive evaluation of data, including disease control rate, overall survival, immune activation, abscopal effects, tumor necrosis, dose ranging, and safety The manuscript is
Intensity Therapeutics Reports INVINCIBLE-4, Presurgical Triple-Negative Breast Cancer Study Update
07:47am, Wednesday, 10'th Sep 2025
A pathological complete response ("pCR") has been observed in the first patient evaluated in Cohort A, where each patient receives two doses of INT230-6 eight days apart, followed by the standard of c
SHELTON, Conn. , June 30, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or "the Company"), a late-stage clinical biotechnology company focused on the discovery and deve
SHELTON, Conn. , June 11, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and deve
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Receive European Medicines Agency Authorization to Initiate Phase 2 INVINCIBLE-4 (SAKK/66/22) Study for INT230-6 in the Treatment of Presurgical Triple-Negative Breast Cancer in France
08:00am, Tuesday, 06'th May 2025
INVINCIBLE-4 (SAKK/66/22) Study continues to recruit patients in eight sites in Switzerland SHELTON, Conn. and BERN, Switzerland , May 6, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: I
Intensity Therapeutics Provides Business Update Highlighting Key Achievements with Lead Drug Candidate INT230-6
08:00am, Friday, 10'th Jan 2025
The US FDA, Health Canada, European Medicines Authority, and the Australian Therapeutic Goods Administration authorized the Company's global, randomized Phase 3 study (INVINCIBLE-3) in Metastatic Soft
World Kinect Corporation Declares Regular Quarterly Cash Dividend
04:20pm, Thursday, 15'th Jun 2023
MIAMI--(BUSINESS WIRE)--World Kinect Corporation (NYSE:WKC) (the “Company”) announced today that its board of directors has declared a quarterly cash dividend of $0.14 per share, which is payable
World Fuel Services Announces Name Change to World Kinect
01:55pm, Thursday, 15'th Jun 2023
MIAMI--(BUSINESS WIRE)--World Fuel Services Corporation (NYSE:INT) (“Company”) today announced it has changed its corporate name to World Kinect Corporation. The Company's shareholders approved th
7 Overvalued Energy Stocks to Sell Before June 2023
07:32pm, Monday, 22'nd May 2023
It may be time to sell some of the top energy stocks, especially as they become overvalued. Sure, according to the International Energy Agency, rising post-Covid demand from China, coupled with tight
Is World Fuel Services (INT) a Great Stock for Value Investors?
10:43am, Friday, 19'th May 2023
Is World Fuel Services (INT) a great pick from the value investor's perspective right now? Read on to know more.
World Fuel Services Corporation (INT) Q1 2023 Earnings Call Transcript
10:59pm, Thursday, 27'th Apr 2023
World Fuel Services Corporation (INT) Q1 2023 Earnings Call Transcript.
World Fuel Services (INT) Tops Q1 Earnings Estimates
07:43pm, Thursday, 27'th Apr 2023
World Fuel Services (INT) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.42 per share a year ago.
World Fuel Services Corporation Reports First Quarter 2023 Results
04:15pm, Thursday, 27'th Apr 2023
MIAMI--(BUSINESS WIRE)--World Fuel Services Corporation (NYSE: INT) today reported financial results for the first quarter of 2023. Results compared to the same period last year are as follows (unaudi
